• Study on Radiometabolic Therapy with 177Lu-PSMA for Patients with Advanced or Metastatic Tumors

    Not recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    Italy

  • Study of Lisaftoclax and Acalabrutinib for Patients with Newly Diagnosed Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Bulgaria Czechia Spain

  • Study of Venetoclax and Decitabine for Elderly Patients with Newly Diagnosed Acute Myeloid Leukemia Eligible for Stem Cell Transplant

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Italy

  • PET Imaging Study for Large B-Cell Lymphoma Patients Using 89Zr-CED88004S Before and After CAR T-Cell Therapy

    Not recruiting

    4 1 1
    Investigated Diseases:
    Investigated Drugs:
    The Netherlands

  • Study on the Safety of Carbetocin Nasal Spray for Treating Uncontrollable Hunger in Patients with Prader-Willi Syndrome

    Not recruiting

    3 1 1
    Investigated Drugs:
    France Germany Spain

  • Study of Lorlatinib for Patients with ALK+ Anaplastic Large Cell Lymphoma After Ineffective ALK Inhibitor Treatment

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Italy

  • Study on Long-Term Safety of Tegoprubart and Tacrolimus for Preventing Kidney Transplant Rejection in Patients

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    France Germany Spain

  • Study to Evaluate the Effectiveness of Pre-emptive Genotyping to Optimize Tacrolimus Dosage in Patients with Chronic Kidney Disease Awaiting Transplant

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Spain

  • Study on the Effectiveness of Budesonide and Omeprazole for Treating Crohn’s Disease in the Esophagus, Stomach, or Duodenum in Children

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    Poland

  • Study on the Effectiveness of Enfortumab Vedotin and Pembrolizumab for Patients with Advanced Melanoma

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Spain

powered by